Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for PHVS

Stock Name	Pharvaris BV
Ticker	PHVS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	NL00150005Y4

Show aggregate PHVS holdings

News associated with PHVS

Pharvaris N.V. (NASDAQ:PHVS) Stake Decreased by Alps Advisors Inc.: Alps Advisors Inc. lessened its holdings in shares of Pharvaris N.V. (NASDAQ:PHVS – Free Report) by 16.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,633 shares of the company’s stock after selling 7,038 shares during the period. Alps […] - 2025-07-15 06:25:18
Brokerages Set Pharvaris N.V. (NASDAQ:PHVS) PT at $36.20: Pharvaris N.V. (NASDAQ:PHVS – Get Free Report) has been given an average recommendation of “Buy” by the five ratings firms that are covering the company, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report on the stock in the […] - 2025-07-11 04:01:06
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Holdings in Pharvaris (NASDAQ:PHVS): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Pharvaris (NASDAQ:PHVS – Free Report) by 30.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 63,734 shares of the company’s stock […] - 2025-06-10 04:20:48
Pharvaris (NASDAQ:PHVS) Shares Down 5.1% Following Weak Earnings: Pharvaris (NASDAQ:PHVS – Get Free Report)’s share price traded down 5.1% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $15.42 and last traded at $15.29. 6,374 shares were traded during trading, a decline of 91% from the average session volume of 73,499 shares. […] - 2025-05-16 03:00:54
Legal & General Group Plc Has $189,000 Stock Holdings in Pharvaris (NASDAQ:PHVS): Legal & General Group Plc grew its holdings in Pharvaris (NASDAQ:PHVS – Free Report) by 11.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,855 shares of the company’s stock after acquiring an additional 994 shares during the period. Legal & General Group […] - 2025-05-02 05:07:01

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) PHVS holdings

Date	Number of PHVS Shares Held	Base Market Value of PHVS Shares	Local Market Value of PHVS Shares	Change in PHVS Shares Held	Change in PHVS Base Value	Current Price per PHVS Share Held	Previous Price per PHVS Share Held
2026-01-15 (Thursday)	43,920	USD 1,126,548	USD 1,126,548	200	USD 6,004	USD 25.65	USD 25.63
2026-01-14 (Wednesday)	43,720	USD 1,120,544	USD 1,120,544	200	USD -10,976	USD 25.63	USD 26
2026-01-13 (Tuesday)	43,520	USD 1,131,520	USD 1,131,520	0	USD -4,352	USD 26	USD 26.1
2026-01-12 (Monday)	43,520	USD 1,135,872	USD 1,135,872	200	USD 14,317	USD 26.1	USD 25.89
2026-01-09 (Friday)	43,320	USD 1,121,555	USD 1,121,555	300	USD 46,055	USD 25.89	USD 25
2026-01-08 (Thursday)	43,020	USD 1,075,500	USD 1,075,500	0	USD -1,721	USD 25	USD 25.04
2026-01-07 (Wednesday)	43,020	USD 1,077,221	USD 1,077,221	200	USD 47,400	USD 25.04	USD 24.05
2026-01-06 (Tuesday)	42,820	USD 1,029,821	USD 1,029,821	0	USD -35,541	USD 24.05	USD 24.88
2026-01-05 (Monday)	42,820	USD 1,065,362	USD 1,065,362	0	USD -68,512	USD 24.88	USD 26.48
2026-01-02 (Friday)	42,820	USD 1,133,874	USD 1,133,874	100	USD -51,606	USD 26.48	USD 27.75
2025-12-31 (Wednesday)	42,720	USD 1,185,480	USD 1,185,480	0	USD 64,080	USD 27.75	USD 26.25

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PHVS by Blackrock for IE00BYXG2H39

Show aggregate share trades of PHVS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 200 26.250 24.825 24.968 USD 4,994 25.84
2026-01-14 BUY 200 26.680 25.500 25.618 USD 5,124 25.85
2026-01-12 BUY 200 26.560 25.720 25.804 USD 5,161 25.82
2026-01-09 BUY 300 27.105 24.870 25.094 USD 7,528 25.82
2026-01-07 BUY 200 26.770 24.400 24.637 USD 4,927 25.98
2026-01-02 BUY 100 28.430 26.195 26.418 USD 2,642 26.34
2025-12-30 BUY 100 26.350 25.760 25.819 USD 2,582 26.07
2025-12-24 BUY 9 26.020 25.560 25.606 USD 230 26.46
2025-12-24 BUY 9 26.020 25.560 25.606 USD 230 26.46
2025-12-23 SELL -1,209 27.315 25.000 25.232 USD -30,505 27.07 Profit of 2,223 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	200	26.250	24.825	24.968	USD 4,994	25.84
2026-01-14	BUY	200	26.680	25.500	25.618	USD 5,124	25.85
2026-01-12	BUY	200	26.560	25.720	25.804	USD 5,161	25.82
2026-01-09	BUY	300	27.105	24.870	25.094	USD 7,528	25.82
2026-01-07	BUY	200	26.770	24.400	24.637	USD 4,927	25.98
2026-01-02	BUY	100	28.430	26.195	26.418	USD 2,642	26.34
2025-12-30	BUY	100	26.350	25.760	25.819	USD 2,582	26.07
2025-12-24	BUY	9	26.020	25.560	25.606	USD 230	26.46
2025-12-24	BUY	9	26.020	25.560	25.606	USD 230	26.46
2025-12-23	SELL	-1,209	27.315	25.000	25.232	USD -30,505	27.07 Profit of 2,223 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PHVS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	56,549	0	75,525	74.9%
2025-09-18	47,568	0	73,970	64.3%
2025-09-17	32,101	0	557,702	5.8%
2025-09-16	34,786	0	115,574	30.1%
2025-09-15	17,584	0	45,046	39.0%
2025-09-12	15,816	0	23,157	68.3%
2025-09-11	14,265	0	24,459	58.3%
2025-09-10	8,713	0	20,741	42.0%
2025-09-09	27,320	0	158,455	17.2%
2025-09-08	21,623	648	51,838	41.7%
2025-09-05	55,562	22,807	102,429	54.2%
2025-09-04	20,968	0	44,410	47.2%
2025-09-03	5,550	0	22,050	25.2%
2025-09-02	13,271	0	70,857	18.7%
2025-08-29	48,800	0	68,331	71.4%
2025-08-28	2,679	0	9,473	28.3%
2025-08-27	4,044	0	10,560	38.3%
2025-08-26	7,298	0	51,560	14.2%
2025-08-25	16,096	0	34,371	46.8%
2025-08-22	5,181	0	18,807	27.5%
2025-08-21	20,510	5,800	71,003	28.9%
2025-08-20	8,182	0	59,705	13.7%
2025-08-19	23,136	0	293,612	7.9%
2025-08-18	10,821	0	30,087	36.0%
2025-08-15	19,731	0	90,365	21.8%
2025-08-14	11,457	0	39,907	28.7%
2025-08-13	6,881	0	11,162	61.6%
2025-08-12	11,317	0	41,948	27.0%
2025-08-11	14,830	0	83,020	17.9%
2025-08-08	22,309	0	63,697	35.0%
2025-08-07	21,769	0	44,981	48.4%
2025-08-06	12,951	0	27,216	47.6%
2025-08-05	31,530	0	77,138	40.9%
2025-08-04	13,865	0	138,496	10.0%
2025-08-01	31,496	0	61,904	50.9%
2025-07-31	18,493	0	30,113	61.4%
2025-07-30	20,650	0	37,368	55.3%
2025-07-29	13,637	0	21,017	64.9%
2025-07-28	19,564	0	64,294	30.4%
2025-07-25	47,713	0	261,424	18.3%
2025-07-24	42,954	1,224	157,313	27.3%
2025-07-23	141,664	3,905	733,470	19.3%
2025-07-22	1,932	0	2,862	67.5%
2025-07-21	3,120	0	5,687	54.9%
2025-07-18	6,700	0	10,356	64.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE